Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Xuekui Liu

Clinical trials sponsored by Xuekui Liu, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Triple-Drug attack on EGFR-Positive head and neck tumors Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Triple-Drug attack on EGFR-Positive head and neck tumors

Disease control Recruiting now

Researchers are testing whether giving becotatug vedotin, pucotenlimab, and cisplatin before surgery can shrink locally advanced EGFR-positive head and neck squamous cell carcinoma. The trial enrolls 40 adults with stage III or IV disease who have not yet received treatment. Part…

Phase 2 • Sponsor: Xuekui Liu • Aim: Disease control

Last updated Sep 12, 2026 00:00 UTC